Crossmark

BAG3 mutation in a patient with atypical phenotypes of myofibrillar myopathy and Charcot–Marie–Tooth disease

Crossref DOI link: https://doi.org/10.1007/s13258-018-0721-1

Published Online: 2018-08-25

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kim, Seung Ju

Nam, Soo Hyun

Kanwal, Sumaira

Nam, Da Eun

Yoo, Da Hye

Chae, Jong-Hee

Suh, Yeon-Lim

Chung, Ki Wha

Choi, Byung-Ok
Funding

Funding for this research was provided by:

Korean Health Technology R&D Project, Ministry of Health & Welfare (HI14C3484)

Korean Health Technology R&D Project, Ministry of Health & Welfare (HI15C1560)

Korean Health Technology R&D Project, Ministry of Health & Welfare (HI16C0426)

National Research Foundation of Korea (2017R1A2A2A05001356)

National Research Foundation of Korea (2017R1A2B2004699)
License Information

Text and Data Mining valid from 2018-08-25
More Information

Article History

Received: 4 April 2018

Accepted: 18 July 2018

First Online: 25 August 2018

Compliance with ethical standards

:

: Seung Ju Kim, Soo Hyun Nam, Sumaira Kanwal, Da Eun Nam, Da Hye Yoo, Jong-Hee Chae, Yeon-Lim Suh, Ki Wha Chung, and Byung-Ok Choi declare that each of them has no conflict of interest.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: This article does not contain any studies with human participants performed by any of the authors.